Abstract
We have determined the effect of naltrexone, naloxone, [D-Ala 2,D-Leu5]enkephalin (DADLE), and morphine on the μ-S196A opioid receptor knock-in and μ-opioid receptor knockout mouse vas deferens preparations. The antagonists, naltrexone and naloxone, exhibited agonist activity and possessed IC50 values that were 14- and 37-fold greater than morphine on the S196A preparation. Morphine was found to be threefold more potent at S196A relative to wild-type μ-opioid receptor. The mouse vas deferens data suggest that S196 in transmembrane helix 4 of the μ-opioid receptor modulates efficacy. It is proposed that this may be due to decreased dimerization of the receptor. Identical IC50 values of DADLE obtained on the wild-type, S196A knock-in, and μ-opioid receptor knockout preparations support the absence of μ-δ heterodimers in the mouse vas deferens.
Original language | English (US) |
---|---|
Pages (from-to) | 207-210 |
Number of pages | 4 |
Journal | European Journal of Pharmacology |
Volume | 478 |
Issue number | 2-3 |
DOIs | |
State | Published - Oct 8 2003 |
Bibliographical note
Funding Information:We thank Mary Lunzer for conducting the mouse vas deferens experiments. This research was supported by NIH research grants DA01533 (PSP), DA07339, DA0564, DA11806, KO5-DA70554 (HHL) and KO5-DA-00513 (PYL).
Keywords
- Mouse
- Opioid receptor antagonist
- Vas deferens
- μ-Opioid receptor knockout
- μ-Ser196Ala